Synergistic Co-Targeting of BTK and BCL2 in Mantle Cell Lymphoma

被引：1
|
作者：
Li, Yangguang [1 ]
Bouchlaka, Myriam N. [2 ,3 ]
Grindle, Kreg [1 ]
Kahl, Brad S. [4 ]
Miyamoto, Shigeki [5 ]
Yang, David T. [6 ]
Capitini, Christian M. [7 ]
Rui, Lixin [8 ,9 ]
机构：
[1] Dept Med, Madison, WI USA
[2] Univ Madison, Dept Pediat, Madison, WI USA
[3] Univ Madison, Carbone Canc Ctr, Madison, WI USA
[4] Washington Univ, St Louis, MO USA
[5] Dept Oncol, Madison, WI USA
[6] Carbone Canc Ctr, Madison, WI USA
[7] Univ Wisconsin, Dept Pediat, Madison, WI USA
[8] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI USA
[9] Univ Wisconsin, Sch Med & Publ Hlth, Carbone Canc Ctr, Madison, WI USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Therapeutic Targeting of the Bcl2 Family
    Letai, Anthony
    Davids, Matthew S.
    Chonghaile, Triona Ni
    Deng, Jing
    Patel, Luv
    BLOOD, 2013, 122 (21)
  • [32] Synergistic Targeting of BTK and E-Selectin/CXCR4 in the Microenvironment of Mantle Cell Lymphomas
    Basyal, Mahesh
    Zhang, Weiguo
    Patel, Nalini B.
    Piya, Sujan
    Zhang, Hongying
    Fogler, William E.
    Rice, William G.
    Magnani, John L.
    Borthakur, Gautam M.
    Andreeff, Michael
    BLOOD, 2019, 134
  • [33] Inhibition of LINK-A lncRNA overcomes ibrutinib resistance in mantle cell lymphoma by regulating Akt/Bcl2 pathway
    Zhang, Ye
    Lu, Peng
    Zhou, Yan
    Zhang, Lifei
    PEERJ, 2021, 9
  • [34] Effect of cyclophosphamide, BCL2 antisense oligonucleotides and rituximab on mantle cell lymphoma growth in a murine in vivo model.
    Bebb, DG
    Tucker, C
    Williams, ME
    Lestou, V
    Chhanabhai, M
    Bally, M
    Horsman, D
    Masin, D
    Klasa, R
    BLOOD, 2002, 100 (11) : 354A - 354A
  • [35] Inactivating BTK mutations in large B-cell lymphoma in a real-world cohort: Strong correlation with BCL2 translocation
    Schejbel, Lone
    Breinholt, Marie Fredslund
    Gang, Anne Ortved
    Nielsen, Torsten Holm
    Pedersen, Lars Moller
    Hogdall, Estrid
    Norgaard, Peter
    EJHAEM, 2022, 3 (03): : 936 - 939
  • [36] Quadruple-hit pleomorphic mantle cell lymphoma with MYC, BCL2, BCL6, and CCND1 gene rearrangements
    Liu, Wei
    Chen, Xiaoqian
    Fan, Jianlin
    Zhu, Mingqing
    Shen, Hongjie
    Chen, Xiaochen
    Chen, Guanghua
    Duan, Yu
    He, Bin
    Zeng, Zhao
    Wu, Depei
    Pan, Jinlan
    Huang, Haiwen
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (04) : 634 - 637
  • [37] BCL2 overexpression in diffuse large B-cell lymphoma
    Monni, O
    Franssila, K
    Joensuu, H
    Knuutila, S
    LEUKEMIA & LYMPHOMA, 1999, 34 (1-2) : 45 - 52
  • [38] Polatuzumab Vedotin As an Effective Salvage Therapy for Relapsed/Refractory Mantle Cell Lymphoma Resistantance to BTK and BCL Inhibitors
    Yang, Ping
    Li, Chunyuan
    Yang, Yuan
    Liu, Shuozi
    Wang, Jing
    Chen, Yingtong
    Zhang, Weilong
    Jing, Hongmei
    BLOOD, 2024, 144 : 6303 - 6303
  • [39] BCL2 mutations in diffuse large B-cell lymphoma
    Schuetz, J. M.
    Johnson, N. A.
    Morin, R. D.
    Scott, D. W.
    Tan, K.
    Ben-Nierah, S.
    Boyle, M.
    Slack, G. W.
    Marra, M. A.
    Connors, J. M.
    Brooks-Wilson, A. R.
    Gascoyne, R. D.
    LEUKEMIA, 2012, 26 (06) : 1383 - 1390
  • [40] BCL2 MUTATIONS IN DIFFUSE LARGE B-CELL LYMPHOMA
    Schuetz, J.
    Johnson, N.
    Morin, R.
    Marra, M.
    Connors, J.
    Brooks-Wilson, A.
    Gascoyne, R.
    ANNALS OF ONCOLOGY, 2011, 22 : 207 - 207
12345